Literature DB >> 21070890

The blind leading the blind: use and misuse of blinding in randomized controlled trials.

Larry E Miller1, Morgan E Stewart.   

Abstract

The use of blinding strengthens the credibility of randomized controlled trials (RCTs) by minimizing bias. However, there is confusion surrounding the definition of blinding as well as the terms single, double, and triple blind. It has been suggested that these terms should be discontinued due to their broad misinterpretation. We recommend that, instead of abandoning the use of these terms, explicit definitions of blinding should be adopted. We address herein the concept of blinding, propose standard definitions for the consistent use of these terms, and detail when different types of blinding should be utilized. Standardizing the definition of blinding and utilizing proper blinding methods will improve the quality and clarity of reporting in RCTs.
Copyright © 2010 Elsevier Inc. All rights reserved.

Mesh:

Year:  2010        PMID: 21070890     DOI: 10.1016/j.cct.2010.11.004

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  10 in total

1.  Blind analysis: Hide results to seek the truth.

Authors:  Robert MacCoun; Saul Perlmutter
Journal:  Nature       Date:  2015-10-08       Impact factor: 49.962

Review 2.  Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.

Authors:  Ann K Hopton; Hugh Macpherson
Journal:  Chin J Integr Med       Date:  2011-02-27       Impact factor: 1.978

3.  Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?

Authors:  Focke Ziemssen; Bianka Sobolewska
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

4.  General and Domain-Specific Effectiveness of Cognitive Remediation after Stroke: Systematic Literature Review and Meta-Analysis.

Authors:  Jeffrey M Rogers; Rachael Foord; Renerus J Stolwyk; Dana Wong; Peter H Wilson
Journal:  Neuropsychol Rev       Date:  2018-07-13       Impact factor: 7.444

5.  The quality of reporting of RCTs used within a postoperative pain management meta-analysis, using the CONSORT statement.

Authors:  Victoria Borg Debono; Shiyuan Zhang; Chenglin Ye; James Paul; Aman Arya; Lindsay Hurlburt; Yamini Murthy; Lehana Thabane
Journal:  BMC Anesthesiol       Date:  2012-07-04       Impact factor: 2.217

6.  A look at the potential association between PICOT framing of a research question and the quality of reporting of analgesia RCTs.

Authors:  Victoria Borg Debono; Shiyuan Zhang; Chenglin Ye; James Paul; Aman Arya; Lindsay Hurlburt; Yamini Murthy; Lehana Thabane
Journal:  BMC Anesthesiol       Date:  2013-11-19       Impact factor: 2.217

7.  Two Independent Prospectively Planned Blinded Weibull Statistical Analyses of Flexural Strength Data of Zirconia Materials.

Authors:  Malgorzata Roos; Christine Schatz; Bogna Stawarczyk
Journal:  Materials (Basel)       Date:  2016-06-24       Impact factor: 3.623

8.  Does Patient Blinding Influence Clinical Outcomes After Annular Closure Device Implantation? A Propensity Score-Matched Analysis.

Authors:  Gerrit J Bouma; Wimar van den Brink; Larry E Miller; Jasper Fc Wolfs; Mark P Arts
Journal:  Orthop Res Rev       Date:  2019-11-08

9.  ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development.

Authors:  Loris Pignolo; Paolo Tonin; Pierluigi Nicotera; Giacinto Bagetta; Damiana Scuteri
Journal:  Front Neurol       Date:  2022-02-18       Impact factor: 4.003

10.  Who knew? The misleading specificity of "double-blind" and what to do about it.

Authors:  Thomas A Lang; Donna F Stroup
Journal:  Trials       Date:  2020-08-05       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.